Department of Health and Human Services June 8, 2017 – Federal Register Recent Federal Regulation Documents
Results 1 - 14 of 14
Meeting of the 2018 Physical Activity Guidelines Advisory Committee
As stipulated by the Federal Advisory Committee Act (FACA), the U.S. Department of Health and Human Services (HHS) is hereby giving notice that the fourth meeting of the 2018 Physical Activity Guidelines Advisory Committee (2018 PAGAC or Committee) will be held. This meeting will be open to the public via video cast.
Draft National Toxicology Program Technical Reports; Availability of Documents; Request for Comments; Notice of Meeting
The National Toxicology Program (NTP) announces the availability of three draft NTP Technical Reports (TRs) scheduled for peer review: p-chloro-[alpha],[alpha],[alpha]-trifluorotoluene, dietary zinc, and 2,3-butanedione. The peer review meeting is open to the public. Registration is requested for both public attendance and oral comment and required to access the webcast. Information about the meeting and registration are available at https://ntp.niehs.nih.gov/go/ 36051.
Medicare and Medicaid Programs; Revision of Requirements for Long-Term Care Facilities: Arbitration Agreements
This proposed rule would revise the requirements that Long- Term Care (LTC) facilities must meet to participate in the Medicare and Medicaid programs. Specifically, it would remove provisions prohibiting binding pre-dispute arbitration and strengthen requirements regarding the transparency of arbitration agreements in LTC facilities. This proposal would support the resident's right to make informed choices about important aspects of his or her health care. In addition, this proposal is consistent with our approach to eliminating unnecessary burden on providers.
Bacteriophage Therapy: Scientific and Regulatory Issues; Public Workshop
The Food and Drug Administration (FDA), Center for Biologics Evaluation and Research, and the National Institutes of Health, National Institute of Allergy and Infectious Diseases are announcing a public workshop entitled ``Bacteriophage Therapy: Scientific and Regulatory Issues.'' The purpose of the public workshop is to exchange information with the medical and scientific community about the regulatory and scientific issues associated with bacteriophage therapy.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.